Is it because Big Pharma knows they can just buy their way in? Why no big pharma producing a smart vape pen in the medicinal cannabis market that communicates data by Bluetooth? Don't they have significant resources and ability or will they just buy their way in because they know MYDX is already doing it and plans on bringing the product to market by end of year? What effect will that have on current shareholders?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.